Biolife Solutions (BLFS) Current Deferred Revenue (2010 - 2023)
Biolife Solutions (BLFS) posted quarterly Current Deferred Revenue of $422000.0 for Q1 2023, down 52.85% year-over-year from $895000.0 in Q1 2022, and down 22.99% quarter-over-quarter from $548000.0 in Q4 2022.
Biolife Solutions (BLFS) Current Deferred Revenue (2010 - 2023) Analysis & Trends
Biolife Solutions (BLFS) has reported Current Deferred Revenue for 14 consecutive years, with $422000.0 the latest figure, recorded in Q1 2023.
- In Q1 2023, Current Deferred Revenue fell 52.85% year-over-year to $422000.0; the TTM figure through Mar 2023 stood at $422000.0 (down 52.85% YoY), while the FY2022 annual figure was $548000.0, down 32.68% from the prior year.
- Current Deferred Revenue eased to $422000.0 in Q1 2023 per BLFS's latest filing, from $548000.0 in the prior quarter.
- Across five years, Current Deferred Revenue topped out at $944000.0 in Q2 2021 and bottomed at $324000.0 in Q4 2019.
- Historically, Current Deferred Revenue has averaged $646363.6 across 5 years, with a median of $662000.0 in 2021.
- Annual changes were most pronounced in 2020 — Current Deferred Revenue soared 187.35% — and 2022, when it tumbled 54.34%.
- Biolife Solutions' Current Deferred Revenue stood at $324000.0 in 2019, then jumped by 187.35% to $931000.0 in 2020, then declined by 12.57% to $814000.0 in 2021, then tumbled by 32.68% to $548000.0 in 2022, then declined by 22.99% to $422000.0 in 2023.
- Business Quant data shows BLFS's Current Deferred Revenue at $422000.0 in Q1 2023, $548000.0 in Q4 2022, and $429000.0 in Q3 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn |
| 10 | Biolife Solutions | 1.82 Bn | 1.73 Bn | 18.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 422,000.00 |
| Dec 31, 2022 | 548,000.00 |
| Sep 30, 2022 | 429,000.00 |
| Jun 30, 2022 | 431,000.00 |
| Mar 31, 2022 | 895,000.00 |
| Dec 31, 2021 | 814,000.00 |
| Sep 30, 2021 | 710,000.00 |
| Jun 30, 2021 | 944,000.00 |
| Mar 31, 2021 | 662,000.00 |
| Dec 31, 2020 | 931,000.00 |
| Dec 31, 2019 | 324,000.00 |
| Dec 31, 2018 | 130,000.00 |
| Sep 30, 2018 | 130,216.00 |
| Jun 30, 2018 | 130,216.00 |
| Dec 31, 2017 | 130,000.00 |
| Sep 30, 2017 | 130,216.00 |
| Jun 30, 2017 | 130,216.00 |
| Mar 31, 2017 | 130,216.00 |
| Dec 31, 2016 | 130,216.00 |
| Sep 30, 2016 | 130,216.00 |